Health and Medicine
-
May 15, 2017
RSV-HRV viral interference
RSV infection reduces the risk of infection with human rhinovirus, which could have implications for vaccine development and prevention strategies for viral respiratory tract infections in infants. -
May 11, 2017
EETs contribute to insulin sensitivity
Interventions that increase circulating levels of compounds called EETs may improve insulin sensitivity and treat hypertension. -
May 4, 2017
Study finds male infants at increased risk for NAS
Male infants are more likely at birth than their female counterparts to be diagnosed with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), and to require treatment, according to a new Vanderbilt study published in Hospital Pediatrics. -
May 4, 2017
Study seeks to reverse precancerous stomach lesions
Vanderbilt University Medical Center cancer researcher James Goldenring, M.D., Ph.D., has received a two-year, $200,000 grant from the DeGregorio Family Foundation in Pleasantville, New York, to begin clinical trials of a potential approach for reversing precancerous stomach lesions. -
May 4, 2017
New cell model to help test reproductive disease therapies
Kevin Osteen, Ph.D., Pierre Soupart Professor Obstetrics and Gynecology, and his team at the Women’s Reproductive Health Research Center have developed a three-dimensional organ-on-a-chip cell model that mimics the endometrial lining of the uterus in an effort to test therapeutic interventions for reproductive diseases. -
May 3, 2017
Therapeutic targets for diabetes
Vanderbilt investigators have identified novel regulators of insulin-producing beta-cell proliferation and survival, suggesting new targets for the treatment of type 2 diabetes. -
May 1, 2017
Clue to recurrent C. diff infection
Children who experience recurrent C. diff infections may have fecal inflammatory markers that could predict risk and improve management of these infections.